Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of fosfomycin treatment for uncomplicated urinary tract infections
2015-005700-28Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fosfomycin in Lower Urinary Tract Infection (LUTI) and urinary tract infection (UTI), sponsored by Erasmus MC. Primary endpoint: Urinary fosfomycin concentration. Started Feb 2016; status: active.
02
Drugs
fosfomycin
03
Conditions
Lower Urinary Tract Infection (LUTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on 2015-005700-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005700-28.